Sunday, May 1, 2016

New Session at ASGCT this Year - Industry Matchmaking

http://www.asgct.org/meetings-educational-programs/asgct-annual-meetings/2016-annual-meeting/attendee/special-sessions

Industry Matchmaking Sessions

Wednesday, May 4 – Friday, May 6, 2016
Marriott Wardman Park Hotel
Individually scheduled meetings
New this year, ASGCT’s Industry Matchmaking Sessions will provide an opportunity for abstract presenters at the 19th Annual Meeting to meet one-on-one with a senior industry representative and give a short 5-10-minute presentation of their work to discuss potential new collaborative research agreements, technologies, and products with industry representatives.
Participating companies include:
  • Audentes Therapeutics
  • Bayer
  • BioMarin
  • bluebird bio
  • CRISPR Therapeutics
  • GlaxoSmithKline
  • Lentigen Technology Inc., A Miltenyi Biotec Company
  • Merck
  • Pfizer
  • Precision BioSciences
  • Precision Nanosystems
  • Sangamo BioSciences
  • Sanofi
  • Spark Therapeutics
  • Tocagen
As the abstract deadline for the 19th Annual Meeting has already passed, the Industry Matchmaking Sessions have been filled at this point. The abstract review committees will match each applicant with one company, and the ASGCT office will schedule individual meetings between applicants and company representatives to take place throughout the Annual Meeting.
If you are planning on submitting an abstract at next year’s 20th Annual Meeting, please consider signing up for this unique opportunity in 2017 during the abstract submission process!

1 comment:

  1. The evolution of gene editing technologies [ZFN and CRISPR - Cas9] the elimination of HIV is possible in the future.

    ReplyDelete